Michael Burry, the investor best known for anticipating the 2008 housing collapse, is once again taking a sharply contrarian stance. In Scion Asset Management’s latest 13F filing, the firm disclosed a tightly concentrated portfolio built around bearish options on two of the market’s most prominent artificial intelligence names: Palantir Technologies and Nvidia. Together, those put positions account for roughly 80% of a portfolio valued at about $44 million, making the filing one of the clearest recent expressions of skepticism toward the AI-led equity rally.
The structure of the portfolio matters as much as the names themselves. According to the filing, Scion’s headline bearish trades are tied to 5 million Palantir shares and 1 million Nvidia shares. In a compact book of this size, that degree of concentration is not a routine hedge. It suggests a high-conviction view that enthusiasm surrounding AI-linked equities may have pushed valuations too far, too fast, and that a repricing could follow if earnings growth or investor sentiment begins to cool.
A Classic Burry Contrarian Setup
Burry has long been associated with trades that challenge consensus narratives, and this filing fits that pattern closely. Rather than following momentum into the market’s favorite AI stocks, Scion appears to be leaning against what it sees as excessive optimism. The implied thesis is straightforward: marquee AI names may still be operationally strong, but elevated multiples can become vulnerable when expectations leave little room for disappointment.
The filing portrays the portfolio less as a diversified basket and more as a defined market thesis. Scion is not spreading risk broadly across dozens of small positions. Instead, it is placing a limited number of concentrated bets where valuation and narrative appear, in Burry’s view, most stretched. That is consistent with his reputation for taking bold positions when he believes the market is mispricing reality.
Not Just Defensive: New Bullish Bets in Healthcare and Energy
Importantly, Scion did not simply build a one-sided anti-AI portfolio. The firm also opened call option positions in Pfizer and Halliburton, indicating that Burry still sees selective upside opportunities in sectors with different drivers from technology momentum. Pfizer represents exposure to large-cap pharmaceutical cash flows, while Halliburton offers leverage to energy services and the cyclical potential of oilfield activity.
These additions suggest that Scion is rotating capital toward areas it may view as more grounded in cash generation, business cycles, and clearer catalysts. If healthcare pipelines improve or if energy demand and capital spending remain resilient, those bullish options could offset part of the risk from the AI short thesis. In that sense, the filing is not only a bearish statement on one theme; it is also a relative-value expression favoring sectors outside the center of current market excitement.
Broader Equity Positioning Shifts
Beyond the options book, Scion also adjusted its equity holdings in ways that reinforce this broader rotation. The firm doubled its stake in Lululemon Athletica and initiated new positions in SLM Corporation and Molina Healthcare. Taken together, those additions point to selective confidence in U.S. consumer resilience, student lending, and managed care—areas that may offer steadier revenue visibility than highly narrative-driven technology trades.
The filing further shows Scion stepping away from prior positions tied to Chinese e-commerce and exiting U.S. health insurers. As described in the source material, that move appears aligned with an effort to reduce exposure to geopolitical friction, regulatory overhangs, and macro uncertainty. In practical terms, Scion seems to be narrowing its portfolio toward what it sees as cleaner domestic opportunities with more identifiable near- to medium-term catalysts.
Why the Concentration Stands Out
One of the most striking elements of the filing is the portfolio’s overall structure. Scion now holds three core equity positions and four options bets, but the options dominate the economic value of the portfolio. That means the strategy is highly directional and timing-sensitive. Unlike a long-only allocation designed to be held through multiple market cycles, this is a setup built for volatility, with outcomes that may diverge sharply depending on whether the market’s AI enthusiasm persists or fades.
If AI leaders continue to post strong earnings and maintain institutional inflows, put options on Palantir and Nvidia could lose value quickly. But if growth expectations soften, valuation multiples compress, or market narratives shift away from AI exuberance, the payoff from such concentrated bearish positions could be significant. The calls in healthcare and energy provide some counterbalance, but they do not erase the reality that Scion is making a forceful macro-style statement through single-theme positioning.
The Timing Problem for Contrarian Trades
The filing also revives a familiar debate around Burry’s investing style: being right on valuation is not always the same as being right on timing. While his legacy remains tied to the successful short against the housing bubble, some of his later macro and equity calls have drawn criticism for being early or ineffective in execution. The source article notes that previous bearish wagers against Tesla and major market indexes did not always pay off in the expected way, underscoring how difficult it can be to translate a broad thesis into a profitable trade window.
That same challenge applies here. AI stocks have continued to benefit from strong earnings narratives, rising capital expenditure linked to data centers and chips, and persistent institutional appetite for the theme. In markets driven partly by fundamentals and partly by powerful storytelling, crowded optimism can last much longer than skeptics expect. As a result, Burry’s current AI puts may prove prescient, premature, or simply wrong depending on how long the market is willing to support rich valuations.
What Investors May Take From the Filing
For investors, the key significance of the filing lies less in whether Burry is ultimately correct and more in what the portfolio says about fault lines in the current market. Scion is effectively arguing that the most celebrated corner of the equity market deserves the most scrutiny, while healthcare, energy services, and selective domestic names may offer better risk-reward profiles. It is a rotation away from crowded narrative trades and toward sectors perceived as more tied to cash flow, defensiveness, or cyclical value.
At the same time, the filing is a reminder that concentrated portfolios can magnify both conviction and risk. Scion’s latest book reads like an investment argument expressed through capital allocation: bearish where hype appears loudest, constructive where valuation and business fundamentals seem more grounded. Whether that thesis plays out will depend not only on fundamentals, but also on sentiment, liquidity, and the market’s tolerance for elevated expectations.
In short, Scion’s latest disclosure presents Michael Burry in familiar form—skeptical of consensus, willing to be visibly contrarian, and comfortable concentrating capital around a strong view. For market participants tracking institutional positioning, the filing offers a useful snapshot of where one of Wall Street’s most closely watched skeptics believes the next pressure points may emerge.